(Q44610329)

4 December 2017

title

Insulin and losartan reduce proteinuria and renal hypertrophy in the pregnant diabetic rat (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-2143(03)00113-6

19 March 2024

1 reference

Noam Natif

1

1 reference

4 December 2017

Fabiana Sclarovsky-Benjaminov

2

1 reference

4 December 2017

David Jonathan Van Dijk

3

1 reference

4 December 2017

Jacklin Sulkes

4

1 reference

4 December 2017

Uzi Gafter

5

1 reference

4 December 2017

Geoffrey Boner

6

1 reference

4 December 2017

Arie Erman

7

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14532904

19 March 2024

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0022214303001136?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-2143(03)00113-6

https://api.elsevier.com/content/article/PII:S0022214303001136?httpAccept=text/plain

19 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-2143(03)00113-6

19 March 2024

published in

Translational Research

1 reference

4 December 2017

volume

142

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

166-171

1 reference

Role of angiotensin II in diabetic nephropathy.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Diabetic nephropathy: pregnancy performance and fetomaternal outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Angiotensin-converting enzyme in epithelial and neuroepithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Regulation of intrarenal angiotensin II in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal link

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Losartan and fetal toxic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Angiotensin-II-receptor inhibitors in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900113-6

Protein turnover in the hypertrophying kidney

7 January 2021

13

1 reference

https://api.crossref.org/works/10.1016/S0022-2143(03)00113-6

19 March 2024

Identifiers

1 reference

4 December 2017

1 reference